Three hot spots of GABA raw materials: sleep, mood, height, where is the next stop for brand layout?
Under the wave of health consumption reconstruction in the post-epidemic era, GABA (γ-aminobutyric acid) is no longer just a synonym for "sleep-aiding ingredient". It is accelerating the breakthrough of multiple potential tracks such as functional foods, health products and even children's nutrition products with a posture of diversified applications and cross-generational needs. The evolutionary path of GABA is a microcosm of the transformation of China's functional health market-from a single effect to compound intervention, from niche cognition to popularization, from mood and sleep regulation to adolescent growth, stress management and even chronic health conditioning. For brands and raw material application companies, it is time to re-evaluate the strategic value of GABA.
From "good sleep" to "good mood" and "good growth": GABA's triple market channel has been opened.
1.The sleep track continues to increase, and GABA replaces melatonin as a new hot spot
The "2025 China Sleep Health Survey Report" released by the China Sleep Research Society shows that the sleep distress rate of people aged 18 and above in my country has reached 48.5%. This means that one in every two adults is experiencing difficulty falling asleep, waking up easily at night, or waking up early. At the same time, China's sleep economy market has been growing continuously in recent years. In 2023, the market size of China's sleep economy industry reached 495.58 billion yuan, an increase of 8.6% year-on-year. With the continuous improvement of the market penetration rate of sleep products and the increasing number of product types, the market size of China's sleep economy will maintain a growth trend, and it is expected that the market size will reach 658.68 billion yuan in 2027. Among them, sleep-aiding functional foods have become one of the important forces supporting the sleep economy, which is significantly higher than the overall nutrition industry. The traditional main ingredient melatonin is experiencing a "decline in trust dividend": frequent disputes over dependence and safety have caused consumers to gradually turn to GABA, which is more gentle and has no side effects. GABA is gradually becoming the "new mainstream" of the market. Under this trend, GABA is rapidly applied to multi-form products such as soft candies, beverages, oral liquids, and compressed candies, providing brands with more innovative and emotionally associative development ideas.
2. Emotion and stress management: The hidden value of GABA is redefined
In recent years, the mental state of people in the workplace and on campus has shown a trend of high tension. In the context of the normalization of "mild depression", consumers' focus is no longer limited to falling asleep itself, but extends from "being able to sleep" to "being able to relax", "emotional stability" and "stress relief".
GABA is a natural ingredient with neurotransmitter regulation. It can indirectly affect cortisol levels by relieving stress, and synergize with ingredients such as L-theanine to promote alpha brain wave activity in a relaxed state. Studies have shown that GABA can promote neural relaxation mechanisms by regulating brain electrical activity. Related experiments show that it has a positive effect on relieving stress reactions, and performs better than the placebo group in emotional management. As a non-drug ingredient, its application safety has received widespread attention.
This also explains why more and more brands prefer GABA as one of the main ingredients when developing "stress relief soft candies" and "anti-internal consumption drinks".
3. New hot spots: GABA is rapidly rising in the adolescent height development market
"Height management" is becoming a new core keyword for Chinese family health consumption. The "2024 Children's Height Status Report" shows that 57% of children do not get full genetic points for height, which is still a gap with parents' expectations. The pioneers have seen the effect.
GABA is the new variable in this high-growth track. Clinical studies have found that GABA can promote bone development by stimulating the pituitary gland to secrete growth hormone (GH), and is currently one of the few "soft" height intervention components with scientific mechanism support. The results of domestic clinical trials show that the subjects who took oral GABA all grew taller to varying degrees. Among them, the men in the experimental group grew 0.43cm taller than the natural growth control group per month, and the women grew 0.24cm taller than the natural growth control group per month, with an average of 0.36cm taller in total; in addition, the experiment also counted the growth rate (HV) of the subjects. The HV of the physiological short group before treatment was 3.32cm/year, and after treatment it was 7.29cm/year, and the HV of the pathological short group before treatment was 2.82cm/year, and after treatment it was 6.21cm/year. GH secretion is most vigorous during deep sleep, and GABA indirectly enhances GH release by increasing the proportion of deep sleep; it also helps to improve stress during the learning period, and improves attention and cognitive response. Trend reminder: New categories such as "functional milk drinks", "children's growth soft candies", and "nutritional growth milk powder" spawned by height anxiety are rapidly forming a standardized formula system.
The value of GABA is far more than "sleep aid". Against the background of the growing demands for emotional health, adolescent growth and sub-health intervention, GABA is gradually moving towards the core track of functional foods.
GABA, as a raw material that combines the three effects of "non-drug intervention + nutritional enhancement + sleep assistance", is becoming one of the core targets for formula upgrades.
In addition, for application-end companies, the quality stability, solubility, and activity retention rate of GABA raw materials are core elements that cannot be ignored in large-scale production.